Home Current Issue Previous Issues Publish Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > April 2012 - Volume 34 - Issue 3 > Peritransplant Psychiatric Evaluation of Patients With Fanco...
Text sizing:
A
A
A
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e31824c9623
Original Articles

Peritransplant Psychiatric Evaluation of Patients With Fanconi Anemia

Kearney, Julia A. MD*; Hay, Jennifer L. PhD*; Halpern, Lauren BA*; Boulad, Farid MD

Collapse Box

Abstract

Patients with Fanconi anemia (FA) referred for stem cell transplantation (SCT) have multiple psychosocial risk factors and often present in distress in the peritransplant period. Twenty-two patients with FA were referred for psychiatry consultation before, during, or after SCT, across a 13-year period at Memorial Sloan-Kettering Cancer Center. The most common diagnoses were mood (50%), adjustment (46%), and anxiety (23%) disorders and delirium (23%); the most common psychiatric symptoms were anxious/depressed (86%), withdrawn (64%), and aggressive (59%) symptoms. Etiology of the diagnoses and symptoms included: chronic childhood illness, physical and/or neurodevelopmental disability, presence of a genetic syndrome, presence of a cancer predisposition syndrome, exposure to therapeutic androgens, and exposure to pediatric SCT. However, the degree of influence of the different factors could not be determined. In addition, other factors such as impact of sibling illness or loss, extent of treatment nonadherence, level and significance of neurodevelopmental pathologies were identified. Future prospective and possibly multicenter studies will need to be generated for a better understanding and more complete factor analysis.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.